Likewise, for CD34, one early study of mixed ALL, including 18 Ph+ BCP, 33 Ph− BCP, and 24 T‐ALL patients, found an overall association between CD34 expression and EOI MRD, but also found a higher prevalence of CD34 positivity in the Ph+ group [48]. Here, CD34 is linked to acute lymphoblastic leukemia.